Latest 10-Q quarterly reports

Transuite.Org Inc. reports Q1 2026 revenue of $121,784, driven by e-bike charging and online education, alongside significant strategic acquisitions and platform development.

Exousia Bio, Inc. (formerly LAMY) has transitioned its business focus to clinical-stage biotechnology, specifically exosome therapeutics for oncology, and reported a net loss for the nine months ended February 28, 2026.

Nobility Homes, Inc. reported a decrease in net sales and net income for the second quarter of fiscal year 2026 compared to the prior year, citing economic uncertainties and supply chain issues.

Stark Focus Group Inc. reported a net loss of $3,726 for the first quarter of 2026, with no revenue and a persistent working capital deficiency, raising concerns about its ability to continue as a going concern.

Vince Holding Corp. reported a 10.5% increase in net sales for the first quarter of fiscal year 2026, but experienced a wider net loss compared to the prior year period.

All in FutureTech Alliance reported a significant revenue decrease in Q1 2026, driven by lower in-person and mobile gaming income, while also announcing a major acquisition and a reverse stock split.

SafeSpace Global Corporation's Q3 2026 Form 10-Q reveals initial revenue generation but significant operating losses and a substantial impairment charge, raising going concern doubts.

Pharma-Bio Serv, Inc. announced its financial results for the second quarter of fiscal year 2026, reporting an increase in net income and revenues, driven by growth in its Puerto Rico consulting segment.

Sentient Brands Holdings Inc. files an amended Q1 2026 report to restate financial statements due to reclassifications, with no impact on operations or total assets/liabilities.

Crisp Momentum Inc. reports significant operational expenses and net loss for Q3 2026, driven by stock-based compensation and expanded operations.

Dave & Buster's reported a 1.5% decrease in total revenues for the first quarter ended May 5, 2026, driven by a 5.4% drop in comparable store sales, while net income fell significantly year-over-year.

DevvStream Corp. filed its Form 10-Q for the quarter ended April 30, 2026, detailing significant net losses and ongoing liquidity concerns, alongside strategic developments including a proposed merger.

Zeo ScientifiX, Inc. announced a significant increase in revenue for the second quarter of fiscal year 2026, driven by strong performance in its allogenic biologic products.

PURE Bioscience reports increased net product sales for Q3 2026 compared to the prior year, though the company continues to operate at a net loss and faces going concern uncertainties.

RF Industries, Ltd. announced a significant turnaround in its Q2 2026 results, reporting a net income of $879,000 compared to a net loss in the prior year period, driven by increased sales and cost management initiatives.

Domo, Inc. reported a net loss of $14.2 million for the quarter ended April 30, 2026, and is in breach of a financial covenant, raising substantial doubt about its ability to continue as a going concern.

Rise Gold Corp. reports increased cash reserves and working capital, but faces ongoing legal challenges regarding its Idaho-Maryland Mine Property rights.

Vitro BioPharma, Inc. filed its Form 10-Q for the quarter ended April 30, 2026, detailing a net loss of $1.55 million and highlighting substantial doubt about its ability to continue as a going concern.

Northern Minerals & Exploration Ltd. reports Q3 2026 results, showing minimal revenue and increased net loss, while managing debt and exploring digital assets.

Glidelogic Corp. reported zero revenue for Q1 2026, with operating expenses increasing to $27,212, while continuing to rely on related party loans for funding.

Helio Corporation reported a significant revenue decrease in its Q2 2026 results, alongside ongoing concerns about its ability to continue as a going concern.

enGene Therapeutics Inc. filed its Form 10-Q for the quarter ended April 30, 2026, detailing financial results, strategic updates including a significant workforce reduction, and progress on its lead drug candidate, detalimogene.

Hammer Technology Holdings Corp. reports continued operational losses and negative working capital, focusing on its fintech initiatives after divesting telecommunications assets.

Comtech Telecommunications Corp. announced its third-quarter fiscal 2026 results, reporting a net loss attributable to common stockholders of $14.3 million, while also detailing a significant divestiture of its Satellite and Space Communications business.

Coda Octopus Group reported a slight revenue decrease in its second quarter, impacted by geopolitical instability in the Middle East and Asia, though profitability improved due to cost management and a favorable revenue mix.

Adobe Inc. announced its second quarter fiscal year 2026 results, showcasing robust revenue growth driven by subscription services and the strategic acquisition of Semrush.

VitaSpring Biomedical reported zero revenue for the first quarter of fiscal year 2025, with a net loss of $80,541 and a significant increase in working capital deficiency.

Odyssey Health reports a net income of $765,890 for the quarter ended April 30, 2026, while maintaining a going concern warning due to significant accumulated deficits.

Gencor Industries saw a 37% decline in quarterly net income due to significant trade show investments and lower revenues, despite a robust backlog and improved gross margins.

AutoZone reports 8.4% net sales growth to $4.8 billion for the third quarter of fiscal 2026, driven by strong domestic commercial sales.